FDA Head Defends Working With Companies - Forbes.com

FDA Head Defends Working With Companies - Forbes.com: "The head of the Food and Drug Administration on Wednesday deflected criticism of his agency's coziness with industry and defended a recent decision not to require new warning labels on a GlaxoSmithKline diabetes drug that may substantially raise the risk of heart attack."